- Home
- VNDA vs AMRN Comparison
VNDA vs AMRN Comparison
Compare VNDA & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- AMRN
- Stock Information
- Founded
- VNDA 2002
- AMRN 1989
- Country
- VNDA United States
- AMRN Ireland
- Employees
- VNDA N/A
- AMRN N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- VNDA Health Care
- AMRN Health Care
- Exchange
- VNDA Nasdaq
- AMRN Nasdaq
- Market Cap
- VNDA 289.0M
- AMRN 339.8M
- IPO Year
- VNDA 2006
- AMRN 1993
- Fundamental
- Price
- VNDA $5.28
- AMRN $16.03
- Analyst Decision
- VNDA Strong Buy
- AMRN Strong Sell
- Analyst Count
- VNDA 3
- AMRN 1
- Target Price
- VNDA $14.00
- AMRN $12.00
- AVG Volume (30 Days)
- VNDA 993.5K
- AMRN 95.5K
- Earning Date
- VNDA 10-29-2025
- AMRN 10-29-2025
- Dividend Yield
- VNDA N/A
- AMRN N/A
- EPS Growth
- VNDA N/A
- AMRN N/A
- EPS
- VNDA N/A
- AMRN N/A
- Revenue
- VNDA $212,074,000.00
- AMRN $226,733,000.00
- Revenue This Year
- VNDA $14.32
- AMRN N/A
- Revenue Next Year
- VNDA $37.05
- AMRN N/A
- P/E Ratio
- VNDA N/A
- AMRN N/A
- Revenue Growth
- VNDA 11.12
- AMRN N/A
- 52 Week Low
- VNDA $3.81
- AMRN $7.08
- 52 Week High
- VNDA $5.70
- AMRN $20.90
- Technical
- Relative Strength Index (RSI)
- VNDA 60.60
- AMRN 44.65
- Support Level
- VNDA $4.72
- AMRN $15.74
- Resistance Level
- VNDA $5.46
- AMRN $17.25
- Average True Range (ATR)
- VNDA 0.24
- AMRN 0.72
- MACD
- VNDA 0.09
- AMRN 0.02
- Stochastic Oscillator
- VNDA 86.13
- AMRN 49.07
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.